Search results
MP Rapid Drugs Of Abuse/Alcohol Test Cup, hereinafter referred to as MP DOA/Alcohol Test Cup, is an immunochromatography based one step in vitro test. It is designed for qualitative determination of drug substances in human urine specimens. This assay may be used in the point of care setting. Below is a list of cut-off concentrations for each drug.
The CEDIATM Opiate Assay is an in-vitro diagnostic medical device intended for the qualitative and semiquantitative assay of opiates in human urine. The assay provides only a preliminary analytical test result.
This manual has been designed to provide practical guidance to national authorities an d drug analysts by describing recommended methods for use in toxicological laboratories for the detection and assay of heroin, cannabinoids, cocaine, amphetamine, methamphetamine and ring-substituted amphetamine derivatives. Special emphasis is given to ...
Clinicians should order testing for the specific (target) drug, or group of drugs e.g. opiates, oxycodone, buprenorphine, benzodiazepines, cocaine, methadone, ethanol, etc. when: the patient is known to have taken a specific drug(s) and/or,
providing the basis for reliable forensic evidence on seized materials containing barbiturate or benzodiazepine derivatives. It is divided into two parts which provide analytical methodologies for the two types of substances with reference to validated techniques.
Drug or alcohol test samples/specimens (typically breath in the case of alcohol and typically urine, oral fluid or hair otherwise) will be collected in private by a certified collector approved by Corporate Human Resources.
1 sty 2019 · Most DAU assays are competitive immunoassays (homogeneous or heterogeneous format) and are subjected to interferences from drug metabolites as well as other drugs with comparable structures to the analyte drug. These assays may be qualitative or quantitative. Alcohol testing employs enzyme assay.
